Partnering News

01.12.2015

HemoShear Announces Collaboration with Pfizer Inc. To Help Identify and Predict Drug-Induced Vascular Injury for Early Stage Compounds

01.12.2015

23andMe Announces Collaboration with Pfizer Inc. to Perform Genetic Research Through 23andMe’s Research Platform

01.08.2015

Repligen Receives Milestone Payment from Pfizer

01.05.2015

Pfizer Acquires Redvax GmbH

12.24.2014

Kissei Announces Licensing Agreement with Pfizer Inc. for KUX-1151, a Novel Investigational Therapy for Gout and Hyperuricemia

12.22.2014

PHILOGEN ANNOUNCES OPTION AND LICENSE AGREEMENT WITH PFIZER INC. TO DEVELOP AND COMMERCIALIZE MULTIPLE ANTIBODY DRUG CONJUGATES AND TARGETED NANOPARTICLES

12.08.2014

iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets

12.08.2014

Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.

12.03.2014

WADA Signs a Global Collaboration Agreement with Pfizer Inc.

12.02.2014

Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration

11.18.2014

Sanguine’s Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research

09.25.2014

Pfizer Completes Acquisition Of InnoPharma